Computer alerts to prompt cholesterol medicine for people with peripheral artery disease
Tests a computer alert for doctors and patients with peripheral artery disease.
Key facts
- Who runs it
- Brigham and Women's Hospital
- Where
- Boston, United StatesSee the site
- Trial code
- Registry title
- Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
- Status
- Recruiting
- People taking part
- 400 people, planned
- Started
- 1 Mar 2023
- Expected to end
- 30 Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Computer Alert
- Record updated
- 17 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with peripheral artery disease (PAD, narrowed leg arteries) who are not taking any medicine to lower LDL cholesterol. It tests an on-screen alert to their doctors.
- Age
- 18 years and older
- Sex
- All sexes
- Disease stage
- Peripheral artery disease (PAD) recorded in the medical history, visit diagnosis or problem list. Patients seen in Cardiovascular Medicine, Primary Care, Podiatry, Vascular Surgery or Diabetology clinics.
- Earlier treatment
- Must not currently be prescribed LDL-C-lowering therapy.
Main reasons for not taking part
- Taking a statin
- Taking ezetimibe or bempedoic acid
- Taking a PCSK9 inhibitor or inclisiran
- Taking a combination of these medicines
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- All patients ≥ 18 years old
- Seen in Cardiovascular Medicine Clinic, Primary Care, Podiatry, Vascular Surgery, and Diabetology
- Medical history entry, visit diagnosis, or problem list entry of PAD
- Not prescribed LDL-C-lowering therapy
Who cannot take part
- Patients taking a statin, ezetimibe, bempedoic acid, a PCSK9 inhibitor, inclisiran or a combination will be excluded
Where in United States
- Brigham and Women's HospitalBoston, United StatesContact: Gregory Piazza, MD, MSTaking people
About the trial
What the trial wants to find out
This single-center, 400-patient, randomized controlled trial assesses the impact of a patient- and provider-facing EPIC Best Practice Advisory (BPA; alert-based computerized decision support tool) to increase guideline-directed utilization of statin and statin-alternative oral LDL-C lowering therapies in patients with PAD who are not being prescribed LDL-C-lowering therapy.
The 2 groups in the trial
- AlertTreatment being tested
Alert-based CDS will consist of an on-screen electronic alert that will notify the clinician that the patient has an indication for LDL-C-lowering therapy but is not prescribed any. The clinician will have the opportunity to proceed to an order template through which appropriate lipid-lowering can be prescribed. The clinician could also elect to learn more about current evidence-based recommendations for LDL-C lowering in the PAD population. Finally, the clinician could elect to proceed without ordering oral LDL-C-lowering therapy or reading evidence-based recommendations for LDL-C lowering but would have to provide a rationale for not doing so.
Treatment: Computer Alert
- No AlertNo study treatment, for comparison
No on-screen notification will be issued to the clinician
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
- Plain-language title
- Computer alerts to prompt cholesterol medicine for people with peripheral artery diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 17 June 2026